Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase.
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase. Blood. 1995 Nov 01; 86(9):3322-6.